FDA Inspection 1275741 — Avent, Inc.

Avent, Inc. — FEI 3006646024

The FDA completed an inspection of Avent, Inc. on Jul 10, 2025 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 10, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tucson, AZ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.